Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: The stem cell trial of recovery enhancement after stroke 2 randomized controlled trial

Stroke

Volumn 43, Issue 2, 2012, Pages 405-411

  England, Timothy J ^a   Abaei, Maryam ^a   Auer, Dorothee P ^a   Lowe, James ^a   Jones, D Rhodri E ^a   Sare, Gillian ^a   Walker, Marion ^a   Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

CD34; granulocyte colony stimulating factor; hematopoietic stem cell; stroke recovery

Indexed keywords

IRON; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AGED; ARTICLE; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; INFECTION; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; LOW BACK PAIN; LUNG EMBOLISM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; STEM CELL MOBILIZATION; T LYMPHOCYTE; URINARY TRACT INFECTION;

AGED; ANTIGENS, CD34; BONE MARROW CELLS; BRAIN; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DOUBLE-BLIND METHOD; ECHO-PLANAR IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECOVERY OF FUNCTION; STROKE; TREATMENT OUTCOME;

EID: 84856410426     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.636449     Document Type: Article

References (21)

1. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med. 2007;357:562-571. (Pubitemid 47236281)
2. England TJ, Gibson CL, Bath PM. Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review. Brain Res Rev. 2009;62:71-82.
3. Simmers RN, Webber LM, Shannon MF, Garson OM, Wong G, Vadas MA, et al. Localization of the G-CSF gene on chromosome 17 proximal to the breakpoint in the t(15;17) in acute promyelocytic leukemia. Blood. 1987;70:330-332. (Pubitemid 17111284)
4. Schneider A, Kruger C, Steigleder T, Weber D, Pitzer C, Laage R, et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest. 2005;115: 2083-2098. (Pubitemid 41134150)
5. Lee ST, Chu K, Jung KH, Ko SY, Kim EH, Sinn DI, et al. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Research. 2005;1058:120-128. (Pubitemid 41416806)
6. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, et al. Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature. 1989; 337:471-473. (Pubitemid 19047464)
7. Jendelova P, Herynek V, Urdzikova L, Glogarova K, Rahmatova S, Fales I, et al. Magnetic resonance tracking of human CD34-progenitor cells separated by means of immunomagnetic selection and transplanted into injured rat brain. Cell Transplant. 2005;14:173-182.
8. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416:542-545. (Pubitemid 34288856)
9. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32:1005-1011. (Pubitemid 32285175)
10. Sprigg N, Bath PM, Zhao L, Willmot MR, Gray LJ, Walker MF, et al. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem Cell Trial of Recovery Enhancement After Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke. 2006;37:2979-2983. (Pubitemid 44913858)
11. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34-cell determination by flow cytometry: International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213-226.
12. Bornhauser M, Theuser C, Soucek S, Holig K, Klingebiel T, Blau W, et al. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: A retrospective analysis. Haematologica. 2000;85:839-847.
13. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res. 2003;73:296-307. (Pubitemid 36918093)
14. Kim D, Chun BG, Kim YK, Lee YH, Park CS, Jeon I, et al. In vivo tracking of human mesenchymal stem cells in experimental stroke. Cell Transplant. 2008;16:1007-1012. (Pubitemid 351732842)
15. Daldrup-Link HE, Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology. 2003;228:760-767. (Pubitemid 37025487)
16. Taguchi A, Wen Z, Myojin K, Yoshihara T, Nakagomi T, Nakayama D, et al. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model. Eur J Neurosci. 2007;26: 126-133. (Pubitemid 47035445)
17. Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte colonystimulating factor for acute ischemic stroke: A randomized controlled trial. CMAJ. 2006;174:927-933.
18. AXIS Study Collaborative Group, Schabitz WR, Laage R, Schwab S, Schneider D, Hamann G, et al. Ax 200 (G-CSF) for the treatment of ischemic stroke. Stroke. 2008;39:561.
19. Bath PM, Sprigg N. Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke. Cochrane Database Syst Rev. 2006;3:CD005207.
20. Schneider A, Kuhn HG, Schabitz WR. A role for G-CSF (granulocytecolony stimulating factor) in the central nervous system. Cell Cycle. 2005;4:1753-1757. (Pubitemid 41827320)
21. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40:e647-e656.